Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
linear decrease » linear increase (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
Showing 81 - 100 results of 5,660 for search '(( significant ((clinical decrease) OR (linear decrease)) ) OR ( significant side decrease ))', query time: 0.34s Refine Results
  1. 81
    Enrollment flow-chart.

    Enrollment flow-chart. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 82
    Table 1 -

    Table 1 - by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 83
    Middle cerebral artery mean flow velocity at three time points.

    Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 84
    Optic Nerve Sheath Diameter (ONSD) in mm, measured by ultrasound.

    Optic Nerve Sheath Diameter (ONSD) in mm, measured by ultrasound. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 85
    ONSD at T14 and six months after ICU discharge.

    ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 86
    Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US.

    Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 87
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Save to List
    Saved in:
  8. 88
    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.

    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Save to List
    Saved in:
  9. 89
    Predicted confidence scores and 95% confidence intervals for the range of observed knowledge scores for barrier scores of 12, 23 and 36.

    Predicted confidence scores and 95% confidence intervals for the range of observed knowledge scores for barrier scores of 12, 23 and 36. by Lisa Thiele (6468056)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Distribution of responses to vital signs.

    Distribution of responses to vital signs. by Lisa Thiele (6468056)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Survey tool development process.

    Survey tool development process. by Lisa Thiele (6468056)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    Respondent characteristics.

    Respondent characteristics. by Lisa Thiele (6468056)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Elevated concentrations of serum MMA among participants with decreased cognitive performance.

    Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

    Published 2025
    Save to List
    Saved in:
  14. 94
    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B).

    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    Complication subgroup analysis of the RAAS system in T2DM patients.

    Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 96
    Flow diagram of patient selection and subgroup classification.

    Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 97
    The values of angiotensin II

    The values of angiotensin II by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 98
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 99
    General characterization of T2DM patients and healthy controls.

    General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups.

    Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: